Live Breaking News & Updates on Fast track designation

Stay informed with the latest breaking news from Fast track designation on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Fast track designation and stay connected to the pulse of your community

Allogene Therapeutics Awarded Grant from the California Institute for Regenerative Medicine to Advance Development of an Allogeneic CAR T in Renal Cell Carcinoma

$15 million CIRM Grant Supports the Ongoing Phase 1 TRAVERSE Trial Evaluating ALLO-316 in Patients with Advanced or Metastatic Renal Cell Carcinoma ALLO-316 Illustrates Proof-of-Concept in RCC and...

United-states , California , South-san-francisco , American , Christine-cassiano , Zachary-roberts , Twitter , Research-development , Nasdaq , California-institute-for-regenerative-medicine , Allogene-therapeutics-inc , Drug-administration

FDA Grants Fast Track Designation to CTX-009 in Biliary Tract Cancer

The combination of bispecific antibody CTX-009 and chemotherapy received Fast Track Designation for advanced, previously treated biliary tract cancers.

Thomas-schuetz , Drug-administration , Compass-therapeutics-inc , Fast-track , Fast-track-designation , Compass-therapeutics , Track-designation , Clinical-oncology , Biliary-tract-cancer , Fda-fast-track-designation ,

ASCO 2024 | Ascentage Pharma to Present Four Studies, Including an Oral Report Featuring the Latest Data of Olverembatinib in SDH-Deficient GIST

ASCO 2024 | Ascentage Pharma to Present Four Studies, Including an Oral Report Featuring the Latest Data of Olverembatinib in SDH-Deficient GIST
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Guangdong , Jilin , China , Hangzhou , Zhejiang , United-states , Hong-kong , Suzhou , Jiangsu , Melbourne , Victoria , Australia

ASCO 2024 | Ascentage Pharma To Present Four Studies, Including An Oral Report Featuring The Latest Data Of Olverembatinib In SDH-Deficient GIST

ASCO 2024 | Ascentage Pharma To Present Four Studies, Including An Oral Report Featuring The Latest Data Of Olverembatinib In SDH-Deficient GIST
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

Melbourne , Victoria , Australia , Rockville , Illinois , United-states , Chicago , Guangdong , Jilin , China , Mccormick-place , Guangzhou

Sage Therapeutics Announces First Quarter 2024 Financial Results and Highlights Pipeline and Business Progress

Sage Therapeutics Announces First Quarter 2024 Financial Results and Highlights Pipeline and Business Progress
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Cambridge , Cambridgeshire , United-kingdom , Matthew-henson , Barry-greene , Ashley-kaplowitz , National-pregnancy-registry-for-antidepressants , Sage-therapeutics-inc , European-medicines-agency , Biogen-inc , Nasdaq , Regulatory-agency

HOOKIPA Pharma Inc. (HOOK) Announces Pivotal Phase 2/3 Trial Design for HB-200 plus Pembrolizumab

HOOKIPA Pharma Inc. (HOOK) Announces Pivotal Phase 2/3 Trial Design for HB-200 plus Pembrolizumab
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states , American , Joern-aldag , Michael-kaiser , Hookipa-pharma-inc , Nasdaq , American-society-of-clinical-oncology , Pharma-inc , Drug-administration , University-of-chicago-medicine , Exchange-commission , European-society-for-medical-oncology-annual-congress

Long-term Complete Response to Can-Fite's Namodenoson in Patient with Advanced Liver Cancer: Article Published in a Leading Scientific Journal

Can-Fite BioPharma Ltd. , a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory diseases, today announced it published an article...

Israel , United-states , Romania , American , Motti-farbstein , American-cancer-society , Drug-administration , Data-monitoring-committee , Fite-biopharma-ltd , European-medicines-agency , Can-fite-biopharma , Therapeutic-medicine-journal

HOOKIPA Pharma Announces Pivotal Phase 2/3 Trial Design for HB-200 in Combination with Pembrolizumab

HOOKIPA Pharma Announces Pivotal Phase 2/3 Trial Design for HB-200 in Combination with Pembrolizumab
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Austria , Vienna , Wien , United-states , American , Joern-aldag , Michael-kaiser , American-society-of-clinical-oncology , European-society-for-medical-oncology-annual-congress , Drug-administration , Exchange-commission , University-of-chicago-medicine

HOOKIPA Pharma Announces Pivotal Phase 2/3 Trial Design for

Phase 2/3 pivotal trial design and protocol for HB-200 in combination with pembrolizumab for the first-line treatment of patients with HPV16+ recurrent or...

Austria , Vienna , Wien , United-states , American , Joern-aldag , Michael-kaiser , European-society-for-medical-oncology-annual-congress , Company-type , Pharma-inc , Drug-administration , American-society-of-clinical-oncology

TME Pharma Publishes 2023 Financial Results and Provides Operating Update

TME Pharma Publishes 2023 Financial Results and Provides Operating Update
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

France , United-states , Spain , Germany , Paris , France-general- , American , Guillaume-van-renterghem , Dennis-riedl , Aram-mangasarian , Merck-keytruda , Pharmanv-euronext